Single App knock-in mouse models of Alzheimer’s disease

Saito, Takashi, Matsuba, Yukio, Mihira, Naomi, Takano, Jiro, Nilsson, Per, Itohara, Shigeyoshi, Iwata, Nobuhisa, Saido, Takaomi C·2014·Nature Neuroscience
DOI 10.1038/nn.3697

Cited by (1,333)

Items 801–900 of 1,333

  1. CCN1 derived from vascular endothelial cells impairs cognitive function in Alzheimer’s disease model mice
    Shuntaro Hirabayashi, Akiko Uyeda, Ichiro Manabe, Yoshino Yonezu, Takashi Saito, Takaomi C. Saido, Hidemi Misawa, Yuki Ogasawara, Kaoru Kinoshita, Rieko Muramatsu · 2025 · Journal of Pharmacological Sciences
  2. Commonly prescribed multi‐medication therapies exert sex‐specific effects on Alzheimer's disease pathology and metabolomic profiles in App NL‐G‐F mice: Implications for personalized therapeutics in aging
    Francesca Eroli, Kristina Johnell, Zeynep Acararicin, Christina Tsagkogianni, Stefania Zerial, Saverio Lancia, María Latorre‐Leal, Vilma Alanko, Sarah Nicole Hilmer, Anna Matton et al. · 2025 · Alzheimer s & Dementia
  3. Experimental evidence that readily diffusible forms of Aβ from Alzheimer’s disease brain have seeding activity
    Simin Song, Qianmin Liu, Ruixiang Chen, Ping Chen, Min Tao, Siyao Li, Liping Guo, Xixi Zhu, Yan Liu, Lu Liu et al. · 2025 · Acta Neuropathologica Communications
  4. Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model
    Jack I. Wood, Maciej Dulewicz, Alicja Szadziewska, Sophia Weiner, Junyue Ge, Katie M. Stringer, Sneha Desai, Lydia Fenson, Diana Piotrowska, Gunnar Brinkmalm et al. · 2025 · Nature Communications
  5. Experimental modeling for tauopathies: An isogenic panel of humanized MAPT knock-in mice
    Takahiro Morito, Naoto Watamura · 2025 · Neuroscience Research
  6. Impaired episodic-like memory in a mouse model of Alzheimer's disease is associated with hyperactivity in prefrontal–hippocampal regions
    Sijie Tan, Wen Han Tong, Ajai Vyas · 2023 · Disease Models & Mechanisms
  7. APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy in Alzheimer’s Disease
    Ekaterina A. Lysikova, Elеna V. Kuzubova, A. I. Radchenko, Evgeny A. Patrakhanov, Kirill Chaprov, Михаил Викторович Корокин, Alexey V. Deykin, Олег Сергеевич Гудырев, М. В. Покровский · 2023 · Molecular Biology
  8. Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer’s disease
    Kenji Yoshida, Daisuke Kato, Shouta Sugio, Ikuko Takeda, Hiroaki Wake · 2023 · Frontiers in Cellular Neuroscience
  9. Lack of occlusal support did not impact amyloid β deposition in APP knock-in mice
    Asuka Murakami, Tetsuya Hara, Chie Yamada-Kubota, Miho Kuwahara, Tomoka Ichikawa, Shogo Minagi · 2021 · Journal of Prosthodontic Research
  10. From synapses to circuits and back: Bridging levels of understanding in animal models of Alzheimer's disease
    Udaysankar Chockanathan, Krishnan Padmanabhan · 2022 · European Journal of Neuroscience
  11. 14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models
    Mary A. Gannon, Bing Wang, Sara Anne Stringfellow, Stephan S. Quintin, Itzel Mendoza, Thanushri Srikantha, A. Claire Roberts, Takashi Saito, Takaomi C. Saido, Erik D. Roberson et al. · 2022 · eNeuro
  12. Alzheimer’s Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons
    Anne E. Harasta, Lars Matthias Ittner · 2017 · Advances in neurobiology
  13. Amyloid-β Oligomers Induce Only Mild Changes to Inhibitory Bouton Dynamics
    Marvin Ruiter, Christine Lützkendorf, Jian Liang, Corette J. Wierenga · 2021 · Journal of Alzheimer s Disease Reports
  14. Prediction and verification of the AD-FTLD common pathomechanism based on dynamic molecular network analysis
    Meihua Jin, Xiaocen Jin, Hidenori Homma, Kyota Fujita, Hikari Tanaka, Shigeo Murayama, Hiroyasu Akatsu, Kazuhiko Tagawa, Hitoshi Okazawa · 2021 · Communications Biology
  15. Protocol for remapping of place cells in disease mouse models
    Heechul Jun, Jasmine Chavez, Allen Bramian, Kei M. Igarashi · 2021 · STAR Protocols
  16. Zinc exacerbates tau-induced Alzheimer-like pathology in C57BL/6J mice
    Xuexia Li, Linfeng Le, Qingqing Shi, Hao Xu, Chao Wang, Yufang Xiong, Xun Wang, Guoli Wu, Qiong Liu, Xiubo Du · 2023 · International Journal of Biological Macromolecules
  17. Neprilysin-sensitive amyloidogenic Aβ versus IDE-sensitive soluble Aβ: a probable mechanistic cause for sporadic Alzheimer’s disease
    Hiroki Sasaguri, Risa Takamura, Naoto Watamura, Naomasa Kakiya, Toshio Ohshima, Ryo Fujioka, Naomi Yamazaki, Misaki Sekiguchi, Kaori Iwata, Yukio Matsuba et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Treatment with BRICHOS domain helps to clarify issues with Alzheimer mouse models
    Jan Johansson · 2024 · EMBO Molecular Medicine
  19. Effects of early tooth loss on chronic stress and progression of neuropathogenesis of Alzheimer’s disease in adult Alzheimer’s model AppNL-G-F mice
    Suzuko Ochi, Kumiko Yamada, Takashi Saito, Takaomi C. Saido, Mitsuo Iinuma, Kagaku Azuma, Kin‐ya Kubo · 2024 · Frontiers in Aging Neuroscience
  20. Alzheimer’s disease and epilepsy: Research hotspots for comorbidity in the era of global aging
    Xu Zhou, Yang Liu, Zhengjuan Wu, Xiaolu Zhang, Hua Tao · 2024 · Epilepsy & Behavior
  21. Intranasal amyloid model of Alzheimer’s disease - potential opportunities and challenges
    Rakesh Kumar Singh · 2025 · Pharmacological Reports
  22. In Vivo Seeding of Amyloid-β Protein and Implications in Modeling Alzheimer’s Disease Pathology
    Qianmin Liu, Simin Song, Lu Liu, Wei Hong · 2025 · Biomolecules
  23. Evaluation of the Alterations in Central Cholinergic Neurotransmission in Aging and Amyloid Precursor Protein Knock‐In Mice
    Itsumi Nagai‐Arakawa, Ikunobu Muramatsu, Junsuke Uwada, Yo Tsuda, Akinori Tokunaga, Ai Irie, Hideyuki Maeda, Yuta Madokoro, Toyohiro Sato, Yuto Uchida et al. · 2025 · Journal of Neurochemistry
  24. Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology
    Eva Schlein, Sara Lopes van den Broek, Tiffany D. Dallas, Ken G. Andersson, Stina Syvänen, Jonas Eriksson, Dag Sehlin · 2025 · ACS Pharmacology & Translational Science
  25. Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer’s pathology in App-knock-in mice
    Wenlin Hao, Qinghua Luo, Ilona Magdalena Szabo, Gilles Gasparoni, Sascha Tierling, Wenqiang Quan, Hsin‐Fang Chang, Gang Wu, Julia Maria Schulze-Hentrich, Yang Liu · 2025 · Alzheimer s Research & Therapy
  26. Intranasal Aβ1−42 Exposure Led To Neurobehavioral Alteration, Neuroinflammatory and Neurodegenerative Molecular Biomarkers in Mice Brain
    Avtar Singh Gautam, Mohammad Zunaid Akhtar, Vaibhav Lasure, Nisha Kumari, Shivam Kumar Pandey, Mangaldeep Dey, Rakesh Kumar Singh · 2025 · Journal of Neuroimmune Pharmacology
  27. Brain DNA Methylation Atlas of AppNL‐G‐F Alzheimer's Disease Model Mice Across Age and Region Reveals Choline‐Induced Resilience
    Andre Krunic, Thomas A Bellio, Benjamin Z Cohen, A. Labadorf, T. Stein, Hong-Huang Lin, Tiffany J Mellott, J. K. Blusztajn · 2025 · Aging Cell
  28. NRF2 activation by CDDO-Im regulates inflammatory and autophagy pathways in human microglial cells
    Ching‐Tung Chu, Akira Uruno, Takafumi Suzuki, Keiko Taguchi, Liam Baird, Fumiki Katsuoka, Masayuki Yamamoto · 2025 · Free Radical Biology and Medicine
  29. CRISPR editing of miR-33 restores ApoE lipidation and amyloid-β metabolism in ApoE4 sporadic Alzheimer’s disease
    B.-G. Kim, Minju Yuk, Moonsu Park, Hongji Ryu, Junhang Park, Hyerin Yu, Sung Soo Park, Jin Tae Hong, Key‐Hwan Lim, Sang‐Bae Han et al. · 2025 · Brain
  30. Loss of ovarian hormones is detrimental in early disease stages of mouse models of Alzheimer’s disease and multi-etiology dementia
    Charly Abi‐Ghanem, Alex K. Opiela, Aaron S. Paul, McKenzie L. Comito, Hao Li, Grace Martino, Nyi‐Rein Kyaw, Abigail E. Salinero, Febronia Morcos Mansour, Richard D. Kelly et al. · 2025 · Biology of Sex Differences
  31. Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
    Sara Lopes van den Broek, Jonas Eriksson, Qiaojun Yang, Nadja M Bucher, Eva Schlein, Lorenzo Jacopo Ilic Balestri, Luke R. Odell, Dag Sehlin, Stina Syvänen · 2025 · Translational Neurodegeneration
  32. Blood extracellular vesicles contribute to the exercise-mediated suppression of brain Aβ pathology in the App knockin mouse model of Alzheimer's disease
    Akiko Takeda, Toshihide Takeuchi, Eiko Nakano Minakawa, Noriko Tanaka, Hideki Mochizuki, Yoshitaka Nagai · 2026 · Neurochemistry International
  33. Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression
    J W Kim, Yerim Hwang, Sumin Kim, Daeyeol Kwon, Jeonghyun Park, Byounggook Cho, Saemin An, Soi Kang, Yunkyung Kim, Seonghun Kim et al. · 2026 · Cell
  34. High Level Forebrain Expression of Active Tau Kinase p38γ Exacerbates Cognitive Dysfunction in Aged APP-transgenic Alzheimer’s Mice
    Prita Riana Asih, Kristie Stefanoska, Emmanuel Prikas, Arne Ittner · 2022 · Neuroscience
  35. Circadian and sleep phenotypes in a mouse model of Alzheimer’s disease characterized by intracellular accumulation of amyloid β oligomers
    Tomoyuki Sato, Tomoyo Ochiishi, Sayaka Higo-Yamamoto, Katsutaka Oishi · 2023 · EXPERIMENTAL ANIMALS
  36. Nicotinic acetylcholine receptor activation induces BACE1 transcription via the phosphorylation and stabilization of nuclear SP1
    Masaki Nakano, Tomohiro Tsuchida, Yachiyo Mitsuishi, Masaki Nishimura · 2023 · Neuroscience Research
  37. Animal Model for Alzheimer’s Disease, Parkinson’s Disease, and Schizophrenia
    Dhanasekaran Sivaraman, Rathinam Arunadevi, Mohana Nandan, Krishnapriya Chandrababu, P. S. Baby Chakrapani, Unnikrishnan Sivan · 2024 · Springer eBooks
  38. Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation
    Gerhard Leinenga, Pranesh Padmanabhan, Jürgen Götz · 2024 · Journal of Alzheimer s Disease
  39. Microglia and Sleep Disorders
    Katherine Picard, Kira Dolhan, Jyoti J. Watters, Marie‐Ève Tremblay · 2024 · Advances in neurobiology
  40. Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer’s disease-like pathology in the APPNL-G-F knock-in mouse model
    Hadir E. AlQot, Rebecca Jane Rylett · 2024 · Scientific Reports
  41. Impaired Cognitive Flexibility With Preserved Learning in an Amyloid Precursor Protein Knock‐In Mouse Model of Amyloidopathy
    Julie R. Dumont, Paul A. S. Sheppard, Chris Fodor, Marco Alexander Coto, Sabrina Yang, Takashi Saito, Takaomi C. Saido, Rebecca Jane Rylett, Marco A. M. Prado, Timothy J. Bussey et al. · 2025 · Genes Brain & Behavior
  42. Histological and Behavioral Phenotypes of a Novel Mutated APP Knock-In Mouse
    Kaja Plucińska, Barry Crouch, Jie Yeap, Sandra Stoppelkamp, Gernot Riedel, Bettina Platt · 2018 · Journal of Alzheimer s Disease
  43. Cytotoxic Aβ Protofilaments Are Generated in the Process of Aβ Fibril Disaggregation
    Toshisuke Kaku, Kaori Tsukakoshi, Kazunori Ikebukuro · 2021 · International Journal of Molecular Sciences
  44. Inbred Mice Again at Stake: How the Cognitive Profile of the Wild-Type Mouse Background Discloses Pathogenic Effects of APP Mutations
    Martine Ammassari‐Teule · 2022 · Frontiers in Behavioral Neuroscience
  45. The effect of Aβ seeding is dependent on the presence of knock-in genes in the AppNL−G−F mice
    Sean G. Lacoursiere, Jiri Safar, David A. Westaway, Majid H. Mohajerani, Robert J. Sutherland · 2022 · Frontiers in Dementia
  46. Multifactorial glial responses and their contributions to Alzheimer's disease continuum
    Masanori Hijioka, Tatsuya Manabe, Takashi Saito · 2023 · Clinical and Experimental Neuroimmunology
  47. In Vivo Models for Evaluation of Drug Efficacy: Demand and Challenges
    Somya Asthana, Vibha Shukla, Anurag Tripathi · 2023 · Springer eBooks
  48. Prospects and Challenges for Alzheimer Therapeutics
    Michael S. Wolfe · 2016 · Elsevier eBooks
  49. Covert strokes prior to Alzheimer’s disease onset accelerate peri-lesional pathology but not cognitive deficits in an inducible APP mouse model
    Mingzhe Liu, Tina L. Beckett, Lynsie A.M. Thomason, Adrienne E. Dorr, Bojana Stefanovic, JoAnne McLaurin · 2021 · Brain Research
  50. Animal Models of Cognitive Deficits for Probiotic Treatment
    Oh Yun Kwon, Seung Ho Lee · 2022 · Food Science of Animal Resources
  51. Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer’s Disease
    Elizabeth Williams, Menekşe Mutlu-Smith, Ashli Alex, Xi Wei Chin, Tara L. Spires‐Jones, Szu‐Han Wang · 2023 · Journal of Alzheimer s Disease
  52. Old and new inflammation and infection hypotheses of Alzheimer’s disease: focus on Microglia-aging for chronic neuroinflammation
    Zhou Wu, Hiroshi Nakanishi · 2017 · Folia Pharmacologica Japonica
  53. NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load
    Theresa Pohlkamp, X. Xian, Connie H. Y. Wong, Murat S. Durakoglugil, Gordon C. Werthmann, T. Saido, Bret M. Evers, Charles L. White, J. Connor, R. Hammer et al. · 2021 · bioRxiv
  54. Microglia Detect Externalized Phosphatidylserine on Synapses for Elimination via TREM2 in Alzheimer’s Disease Models
    Javier Rueda‐Carrasco, Dimitra Sokolova, Sang‐Eun Lee, Thomas Childs, Natália Jurčáková, Sebastiaan De Schepper, Judy Z. Ge, Joanne Lachica, Christina E. Toomey, Oliver J. Freeman et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Defective lysosomal acidification contributes to TNFR1 mediated neuronal necroptosis in Alzheimer’s disease
    Jialiu Zeng, Kholoud Abd-Elraouf, Gavin Wen Zhao Loi, Eka Norfaishanty Saipuljumri, Lance M. O’Connor, Jonathan Indajang, Richard Reynolds, Anna M. Barron, Chih Hung Lo · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Long term rescue of Alzheimer’s deficits in vivo by one-time gene-editing of App C-terminus
    Brent D. Aulston, Kirstan Gimse, Hannah Bazick, Enikö A. Kramár, Donald P. Pizzo, Farbod Shavarebi, Trinity Rust, Sheila Garcia Rosa, Leonardo A Parra‐Rivas, Jichao Sun et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  57. An aging-sensitive compensatory secretory phospholipase that confers neuroprotection and cognitive resilience
    Cinzia Vicidomini, Travis D. Goode, Kathleen M. McAvoy, Ruilin Yu, Conor H. Beveridge, Sanjay N. Iyer, Matheus B. Victor, Noelle Leary, Liam Evans, Michael J. Steinbaugh et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Isotope Encoded chemical Imaging Identifies Amyloid Plaque Age Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity
    Jack I. Wood, Maciej Dulewicz, Junyue Ge, Katie M. Stringer, Alicja Szadziewska, Sneha Desai, Srinivas Koutarapu, Haady B. Hajar, Kaj Blennow, Henrik Zetterberg et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Aβ-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer’s disease
    Vibhavari Aysha Bansal, Jia Min Tan, Hui Rong Soon, Norliyana Zainolabidin, Takaomi C. Saido, Toh Hean Ch’ng · 2024 · eLife
  60. Bibliometric analysis and description of research trends on nutritional management in Alzheimer’s disease patients (1988–2024)
    Chenchen Meng, Bei Li, Zhaoxia Wang, Qing Peng · 2025 · Frontiers in Nutrition
  61. Long-term electroacupuncture and repetitive transcranial magnetic stimulation differentially slow the progression of Alzheimer's disease in AppNL−G−F mice
    Simin Song, Qian-Min Liu, Xi Huang, Ping Chen, Min Tao, Xia Pei, Huaning Wang, Yan Han, Jianguo Chen, Wei Hong et al. · 2025 · Alzheimer s Research & Therapy
  62. The Interaction between Oligodendrocytes and Aβ in Alzheimer's Disease
    Wenjing Wang, Xueyan Huang, Zucai Xu, Changyin Yu · 2025 · Current Alzheimer Research
  63. A synapse perspective on the function of the amyloid precursor protein
    Pia Kruse, Amelie Eichler, Larissa Klukas, Maximilian Lenz · 2025 · Science Progress
  64. A Question of Origins: Non-neuronal Sources of Amyloid-β
    Andrew Octavian Sasmita, Constanze Depp · 2026 · Neuroscience Bulletin
  65. Surgical removal of visceral adipose tissue has therapeutic benefit in male APPNL-F mice
    Samuel McFadden, Yimin Fang, Kathleen Quinn, Mackenzie R. Peck, Jenelle E. Chapman, Tiarra Hill, Andrzej Bartke, Erin R. Hascup, Kevin N. Hascup · 2026 · Frontiers in Endocrinology
  66. Temporal Interference Stimulation Enhances Neural Regeneration
    Sofia Peressotti, Maria Garcia Garrido, Patrycja Dzialecka, Rachel Man Hoi Law, Roberto Portillo Lara, Bethany Geary, Elena Faillace, Shirine Merlo-Nikpay Aslie, Marcelina J. Wojewska, Maria Otero‐Jimenez et al. · 2026 · Advanced Science
  67. Rodent Models of Alzheimer’s Disease
    Abhinav Singh, Shampa Ghosh, Dr. Krishna Kumar Singh, Bhuvaneshwar Yarlagadda, Jitendra Kumar Sinha · 2026 · Contemporary clinical neuroscience
  68. Age‐related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndrome
    Monika Rataj-Baniowska, Paige Mumford, Francesca Prestia, Pauline Stephan, Millie Beament, Marie‐Christine Birling, Chiara Lanzillotta, Letizia Ciafardini, Eugenio Barone, Gloria Lau et al. · 2026 · Alzheimer s & Dementia
  69. Operant House: A versatile open-source platform for automated operant conditioning testing of mice in home cages
    Shintaro Otsuka, Yuriko Nakamura, Aya Ito, K. Suzuki, アヤコ イシカワ, Keiko Matsuda, Shigetomo Suyama, Anis Contractor, Michisuke Yuzaki · 2026 · PLoS ONE
  70. DEAD Box Helicase 24 Is Increased in the Brain in Alzheimer’s Disease and AppN-LF Mice and Influences Presymptomatic Pathology
    Michael Axenhus, Tosca Doeswijk, Per Nilsson, Anna Matton, Bengt G. Winblad, Lars O. Tjernberg, Sophia Schedin‐Weiss · 2024 · International Journal of Molecular Sciences
  71. Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia
    Yuanpu Chiu, Shangzhou Xia, Haowen Qiao, Zhen Zhao · 2024 · American Journal Of Pathology
  72. Novel amyloid-β oligomer-targeted fluorescent probes by introducing branched chain into push-pull type dye
    Rikuto Kashiyama, Hiroyuki Watanabe, Takahiro Akasaka, Masahiro Ono · 2025 · Dyes and Pigments
  73. Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer's disease revealed by PET imaging with [18F]FMPEP-d2 and [18F]MAGL-2102
    Anna Pees, Christopher Daniel Morrone, Junchao Tong, Jian Rong, Tuo Shao, Darcy Wear, Steven H. Liang, Wai Haung Yu, Neil Vasdev · 2025 · Theranostics
  74. The PKCι-β-arrestin2 axis disrupts SORLA retrograde trafficking, driving its degradation and amyloid pathology in Alzheimer’s disease
    Hasibur Rehman, Shun Yan, Shalini Saggu, Mae Aida, Fang Zhang, Yang Shu, Alexis Jones, Amy Trang, Emily Dew, Wenbo Zhi et al. · 2025 · Molecular Neurodegeneration
  75. Involvement of orexin nerves in early stage of Alzheimer's disease model mice and preventive effect of orexin receptor antagonists
    Kazuhiro Hada, Yuki Murata, Yoshiaki Ohi, Sana Hashimoto, Hinata Watanabe, Kayoko Ozeki, Takaomi C. Saido, Takashi Saito, Hiroki Sasaguri, Hiroyuki Mizoguchi et al. · 2026 · Journal of Alzheimer s Disease
  76. Homeostatic plasticity of axonal excitable sites in Alzheimer's disease
    Tania Quintela‐López, Jonathan Lezmy · 2023 · Frontiers in Neuroscience
  77. Two mouse models of Alzheimer’s disease accumulate amyloid at different rates and have distinct Aβ oligomer profiles unaltered by ablation of cellular prion protein
    Silvia A. Purro, Michael Farmer, Elizabeth Noble, Claire J. Sarell, Megan Powell, Daniel Chun-Mun Yip, Lauren Giggins, Leila Zakka, David X. Thomas, Mark A. Farrow et al. · 2023 · PLoS ONE
  78. Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain
    Harshitha Santhosh Kumar, James M. Moore, Adrian C. Steiner, Emmanuel Sotirakis, Benjamin Schärli, Patricia Isnard, Kader Thiam, David Paul Wolfer, Erik C. Böttger · 2023 · Cellular and Molecular Life Sciences
  79. Spatiotemporal development of the neuronal accumulation of amyloid precursor protein and the amyloid plaque formation in the brain of 3xTg-AD mice
    Munenori Ono, Tetsufumi Ito, Sachiko Yamaki, Yoshie Hori, Qing Zhou, Xirun Zhao, Shinji Muramoto, Ryo Yamamoto, Takafumi Furuyama, Hiromi Sakata‐Haga et al. · 2024 · Heliyon
  80. Suppression of the amyloidogenic metabolism of APP and the accumulation of Aβ by alcadein α in the brain during aging
    Keiko Honda, Hiroo Takahashi, Saori Hata, Ruriko Abe, Takashi Saito, Takaomi C. Saido, Hidenori Taru, Yuriko Sobu, Kanae Ando, Tohru Yamamoto et al. · 2024 · Scientific Reports
  81. Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice
    Caleigh A. Findley, Samuel McFadden, Tiarra Hill, Mackenzie R. Peck, Kathleen Quinn, Kevin N. Hascup, Erin R. Hascup · 2024 · Journal of Alzheimer s Disease
  82. The Soluble Platelet‐Derived Growth Factor β Receptor Induces Postoperative Delirium by Downregulating the Clearance of β‐Amyloid in the Brain
    Zongfeng Guo, Chen Zhang, Xiang Wang, Weiguo Chen, Zongxiao Guo · 2025 · Brain and Behavior
  83. Perinatal Choline Supplementation Promotes Resilience Against Progression of Alzheimer's Disease‐Like Brain Transcriptomic Signatures in App NL‐G‐F Mice
    Thomas A. Bellio, Andre Krunic, Mary S. Campion, Rohan Dupaguntla, Adam Thomas Labadorf, Thor D. Stein, Honghuang Lin, Tiffany J. Mellott, Jan Krzysztof Blusztajn · 2025 · Aging Cell
  84. Predict or classify: The deceptive role of time-locking in brain signal classification
    Marco Rusconi, Angelo Valleriani · 2016 · Scientific Reports
  85. Dysfunction of Na+/Ca2+ exchangers is associated with cognitive decline in Alzheimer’s disease
    Shigeki Moriguchi, Satomi Kita, Takahiro Iwamoto, Kohji Fukunaga · 2018 · Folia Pharmacologica Japonica
  86. Activity Rhythms Are Largely Intact in APP NL-G-F Alzheimer’s Disease Mice
    Scott H. Deibel, Bryant Young, Majid H. Mohajerani, Robert J. McDonald · 2019 · Journal of Alzheimer s Disease
  87. Development of a Novel Alzheimer's Disease Model Based on the Theory of the Toxic-conformer of Amyloid β
    Naotaka Izuo, Takahiko Shimizu, Kazuma Murakami, Kazuhiro Irie · 2021 · YAKUGAKU ZASSHI
  88. Photo-Oxygenation: An Innovative New Therapeutic Approach Against Amyloidoses
    Tetsuo Ikeda, Yukiko Hori, Youhei Sohma, Motomu Kanai, Taisuke Tomita · 2021 · Advances in experimental medicine and biology
  89. Improving mouse models for the study of Alzheimer's disease
    Alaina M. Reagan, Kristen D. Onos, Sarah E. Heuer, Michael Sasner, Gareth R. Howell · 2022 · Current topics in developmental biology/Current Topics in Developmental Biology
  90. Unpredictable mealtimes rather than social jetlag affects acquisition and retention of hippocampal dependent memory
    Scott H. Deibel, Leanna M. Lewis, Jillian Cleary, Taylor T.S. Cassell, Darlene M. Skinner, Christina M. Thorpe · 2022 · Behavioural Processes
  91. Etiology matters: genetic and acquired prion diseases engage different mechanisms at a presymptomatic stage
    Walker S. Jackson · 2023 · Neural Regeneration Research
  92. Of Mice and Pose: 2D Mouse Pose Estimation from Unlabelled Data and Synthetic Prior
    Jose Sosa, Sharn E. Perry, Jane Alty, David Hogg · 2023 · Lecture notes in computer science
  93. Reduction of Amyloid-β Production without Inhibiting Secretase Activity by MS-275
    Yachiyo Mitsuishi, Masaki Nakano, Hirotatsu Kojima, Takayoshi Okabe, Masaki Nishimura · 2024 · ACS Chemical Neuroscience
  94. Adenosine deficiency facilitates CA1 synaptic hyperexcitability in the presymptomatic phase of a knockin mouse model of Alzheimer disease
    Mattia Bonzanni, Alice Braga, Takashi Saito, Takaomi C. Saido, Giuseppina Tesco, Philip G. Haydon · 2024 · iScience
  95. Senescent cells maintain viability through adhesion-dependent fragmentation that promotes debris deposition
    Matej Durik, Mona Karout, Daniel Sampaio Gonçalves, Tania Knauer-Meyer, Coralie Spiegelhalter, Nadia Messaddeq, Marco Seehawer, Pauline Stephan, Dmitry V. Bulavin, Yann Hérault et al. · 2026 · Developmental Cell
  96. The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
    Ana Catarina R. G. Fonseca, Rosa Resende, Sandra M. Cardoso, Cláudia Pereira · 2015 · Endoplasmic Reticulum Stress in Diseases
  97. Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer’s disease
    Keiro Shirotani, Masashi Asai, Nobuhisa Iwata · 2017 · The Journal of Biochemistry
  98. Expression of Olfactory-Related Genes in the Olfactory Epithelium of an Alzheimer’s Disease Mouse Model
    Masataka Narukawa, Yuko Mori, Riko Nishida, Suzuka Takahashi, Takashi Saito, Takaomi C. Saido, Takumi Misaka · 2022 · Journal of Alzheimer s Disease
  99. Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
    Bushra Almari, David Brough, Michael Harte, Annalisa Tirella · 2019 · Journal of Visualized Experiments
  100. Animal models of dementia
    Erik D. Roberson, Aimee W. Kao · 2016 · Cambridge University Press eBooks